Gilead Creating Possible
Be Free Of Hep C has been developed and funded by Gilead Sciences Ltd. Information on this webpage is intended for the general public.
Be Free of Hep C
Be Free Of Hep C has been developed and funded by Gilead Sciences Ltd. The information on this webpage is intended for the general public.
Gilead Logo

These pages are intended for the general public

  • Gilead & Elimination
    Overview Contact us
  • Be Free of Hep C
    What is Hep C? Are you at risk? What are the symptoms? Testing and treatment More information
  • Hep C, Ki?
    What is Hep C? Are you at risk? What are the symptoms? Testing and treatment What is Hep C, Ki? More information

These pages are intended for health service providers

  • Elimination Partners
    About Be Free of Hep C Provider Forum Drug and Alcohol Services Commissioners & Service Leaders Prison Services Operational Delivery Networks Celtic Nations
  • Elimination Resources
    Provider Forum Materials Commissioning & Service Standards Disease Awareness & Harm Reduction Testing Strategies Linkage To Care

Accessibility

We are committed to making the Be Free Of Hep C website a welcoming and rewarding source of information and support for everyone who visits. By following the Web Content Accessibility Guidelines (WCAG) 2.0, we aim to offer a user-friendly experience for people of all abilities. The guidelines have three levels of accessibility (A, AA and AAA). We’ve chosen the middle level, AA, as our website target.

This site is intended for residents of the United Kingdom.
© 2021-2025 Gilead Sciences, Inc. All rights reserved.
UK-UNB-2446 | August 2025
Gilead and Gilead logo are trademarks of Gilead Sciences, Inc.

INFORMATION

  • About
  • Accessibility
  • Manage Cookies Settings

LEGAL

  • Privacy Statement
  • Cookie Statement
  • Terms of Use
  • Visit clinicaltrials.gov for information on UK clinical trials
  • Modern Slavery Act

Reporting suspected adverse reactions of medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting line: Yellow Card Scheme available at: www.mhra.gov.uk/yellowcard. Adverse reactions may also be reported directly to Gilead. Adverse reactions related to Gilead products may be reported directly to Gilead via 01223 897 555 or by email to ukmedinfo@gilead.com.

Gilead Logo

You are now leaving www.befreeofhepc.co.uk and visiting a new site which is not owned or controlled by Gilead Sciences.

Gilead Sciences is therefore not responsible for your interactions with the website or the information it provides.

Gilead Logo

You are now leaving www.befreeofhepc.co.uk and visiting another website owned and controlled by Gilead Sciences.